Intérêt actuel des selective progesterone receptor modulators (SPRM) dans l’endométriose
article
OA: closed
CC0
⤵ 7 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This review explores the current interest in selective progesterone receptor modulators (SPRMs) for treating endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- A novel mifepristone-loaded implant for long-term treatment of endometriosis: In vitro and in vivo studies via openalex
- Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study via openalex
- Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study. via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Effects of the progesterone antagonists onapristone (ZK 98 299) and ZK 136 799 on surgically induced endometriosis in intact rats* via openalex
- Genomics' Role in Understanding the Pathogenesis of Endometriosis via openalex
- Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques via openalex
- Progesterone antagonists and progesterone receptor modulators: an overview via openalex
- Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis via openalex
- The evidence for the management of endometriosis via openalex
- Treatment of Endometriosis via openalex
- W2165639852 via openalex
- W2169446553 via openalex
- W2171012392 via openalex
- W2322133447 via openalex
- W2106587450 via openalex
- W1982798184 via openalex
- W2007951223 via openalex
- W2026392453 via openalex
- W2039274017 via openalex
- W2063169494 via openalex
- W2093512443 via openalex
- W2096645222 via openalex
- W1550247880 via openalex
- W2156957181 via openalex
- W2157929167 via openalex
Cited by (7)
- An exceptional case of degenerative endometriosis of the uterine torus 2023
- Progesterone receptor ligands for the treatment of endometriosis 2022
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis) 2018
- Conservative treatment of deep infiltrating endometriosis: review of existing options 2017
- Novel agents for the medical treatment of endometriosis 2014
- 10.1016/s0246-1064(17)67531-5 2000
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:18:53.335890+00:00
License: CC0
· commercial use OK